Trade CSLLY stock anytime, 24x5 in Singapore
Regulated by
Monetary Authority of Singapore (MAS)
Trusted by
400,000+ users
Csl Ltd SPONSORED ADR (Australia) (CSLLY) is trading at US$31.10, down 1.99% today as of Sep 18, 16:00 EDT. The company has a market capitalisation of US$57.97B. Over the past 52 weeks, CSLLY has traded between US$16.01 and US$72.57. On Syfe you can trade CSLLY with $0 commission and add it to your watchlist.
| Previous close | US$31.73 |
|---|---|
| Market cap | US$57.97B |
| 52-week range | US$16.01 – US$72.57 |
| Dividend yield | 2.17% |
| Volume | 65.14K |
| Exchange | US |
Add to Watchlist
Set Price Alert
Csl Ltd SPONSORED ADR (Australia)
CSL Ltd. is a biopharmaceutical company, which engages in the manufacture, marketing, and distribution of biopharmaceutical and allied products. It operates through the following segments: CSL Behring, CSL Seqirus, and CSL Vifor. The CSL Behring segment provides plasma products, gene therapies, and recombinants. The CSL Seqirus segment includes predominantly influenza related products and provides pandemic services to governments. The CSL Vidor segment focuses on the distribution of products in the therapeutic areas of iron deficiency and nephrology. The company was founded on November 2, 1961 and is headquartered in Melbourne, Australia.
Csl Ltd SPONSORED ADR (Australia) (CSLLY) stock is trading at US$31.10, -1.99% from the previous close of US$31.73.
The market cap for Csl Ltd SPONSORED ADR (Australia) (CSLLY) stock is approximately US$57.97B.
The 52-week high for Csl Ltd SPONSORED ADR (Australia) (CSLLY) stock is US$72.57.
The 52-week low for Csl Ltd SPONSORED ADR (Australia) (CSLLY) stock is US$16.01.
Yes, Csl Ltd SPONSORED ADR (Australia) (CSLLY) pays a dividend. The trailing 12-month dividend yield is 2.17%.
Stay on top of CSLLY
Price moves, news and earnings — straight to your inbox.
Est. order value
US$0.00
Snapshot
Popular Stocks in Singapore
